Deferred Tax Assets, Valuation Allowance of Inhibrx Biosciences, Inc. from 31 Dec 2023 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Inhibrx Biosciences, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 31 Dec 2023 to 31 Dec 2024.
  • Inhibrx Biosciences, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 31 Dec 2024 was $21,789,000, a 85% decline year-over-year.
Source SEC data
View on sec.gov
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Inhibrx Biosciences, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $21,789,000 -$124,216,000 -85% 31 Dec 2024 10-K 17 Mar 2025 2024 FY
Q4 2023 $146,005,000 31 Dec 2023 10-K 17 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.